Prosecution Insights
Last updated: October 25, 2026

Wolf, Greenfield & Sacks, P.C.

Technology area: Biotechnology & Pharmaceuticals

651 pending office actions • 294 clients • 549 examiners • 248 art units • 0 of 651 (0%) have an AI response strategy ready

Analysis

WOLF GREENFIELD & SACKS, P.C. has 653 pending office actions in Biotechnology & Pharmaceuticals and 35769 career applications. Its resolved allowance rate is 84.91%, and allowed matters average 3.61 office actions per allowance.

The pending docket indicates a significant volume of active biotechnology and pharmaceutical prosecution. The reported application base provides a broad context for the allowance rate, while the office-action average shows that allowed matters generally involve several examination exchanges. Practitioners can apply these figures to workload and response planning, particularly where claim scope depends on biological disclosure and support. The aggregate data does not establish outcomes for a particular technology, examiner, or claim set.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=35769 apps, methodology: how we score firms)

84.9%
Allowance Rate
n=35769
+0.62σ
Allowance Rate (norm)
n=35769
3.6
OAs to Allowance
n=20063
-0.03σ
OAs to Allow (norm)
n=20063
1084 days
Time to Allowance
n=20063
+9.9pp
Interview Lift
n=35769
31.4%
RCE Rate
n=35769
0.8%
Appeal Rate
n=35769

Rejection Performance (% of received rejections ultimately overcome)

81.0%
§101 Overcome
n=2824
80.5%
§102 Overcome
n=8772
80.4%
§103 Overcome
n=13141
81.6%
§112 Overcome
n=10104

Specialization & Scale

A61K, A61P, G01N
Top CPC Subclasses
17%
Top-3 CPC Share
n=35769
16
Practitioners
n=35769
2235.6
Apps / Practitioner
n=35769

Portfolio Summary

651
Total Pending OAs
423
Non-Final OAs
217
Final Rejections
11
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 205 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

108
Overdue
6
Due this week
50
Due this month
24
Due in next 60 days
17
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 205 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (108)Due ≤ 7 days (6)Due ≤ 30 days (50)Due ≤ 60 days (24)Due later (17)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

338
Hard (52%)
260
Medium (40%)
49
Easy (8%)
4
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only13 (2%)
§101 + other64 (10%)
§103 only163 (25%)
§102 only30 (5%)
§112 only41 (6%)
Double-patenting only8 (1%)
Double-patenting + other67 (10%)
Multi-statute (no §101)261 (40%)
No statute on record4 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

373
Life Sciences
57% of docket
40
Information Tech
6% of docket
20
Communications
3% of docket
86
Semiconductors
13% of docket
121
Mechanical / Eng
19% of docket
11
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

6,510 h
Manual time on pending OAs
1,302 h
Time saved (low, 20%)
2,278 h
Time saved (mid, 35%)
57.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
POHNERT, STEVEN C 5 12.5% +18.2%
CROW, ROBERT THOMAS 5 41.6% +32.5%
CHAMPAKESAN, BADRI NARAYANAN 4 91.0% +55.3%
SHIN, DANA H 4 26.9% +26.9%
DICKINSON, PAUL W 3 63.2% +9.6%
JOHNSON, ALLISON MARIE 3 40.9% +53.3%
RAHMAN, MASUDUR 3 72.9% +31.7%
KONOPKA, CATHERINE ANNE 3 57.5% +66.2%
LIPPOLIS, ALEXANDRA ROSE 3 47.2% +63.6%
BENAVIDES, JENNIFER ANN 3 50.8% +47.3%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17583726 SYSTEM AND METHODS FOR IMPLEMENTING PRIVATE IDENTITY CHAMPAKESAN, BADRI NARAYANAN 71d overdue
18754457 SYSTEM AND METHODS FOR IMPLEMENTING PRIVATE IDENTITY CHAMPAKESAN, BADRI NARAYANAN 38d overdue
18754422 SYSTEM AND METHODS FOR IMPLEMENTING PRIVATE IDENTITY CHAMPAKESAN, BADRI NARAYANAN 38d overdue
19044290 SYSTEMS AND METHODS FOR PRIVATE AUTHENTICATION WITH HELPER NETWORKS CHAMPAKESAN, BADRI NARAYANAN —

Hard Cases (344)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18437965 SYSTEM AND INTERFACES FOR PROCESSING AND INTERACTING WITH CLINICAL DATA LEE, ANDREW ELDRIDGE 163d overdue
17493230 ASSESSING CONDITIONS IN TRANSPLANT SUBJECTS USING DONOR-SPECIFIC CELL-FREE DNA HANEY, AMANDA MARIE 141d overdue
18350194 SYSTEMS AND METHODS FOR MANAGING CLINICAL TRIALS GO, JOHN PHILIP 134d overdue
18281000 SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS TRAN, LIEN THUY 127d overdue
17764145 MULTIDIMENSIONAL MICROFLUIDIC PROTEIN CHARACTERISATION VANNI, GEORGE STEVEN 126d overdue
18696763 MULTI-BEAM ANTENNA ARRAY HAMADYK, ANNA N 118d overdue
17572896 COMPOSITIONS AND METHODS FOR TREATING BASAL FOREBRAIN DISEASE SHOWALTER, ALEXANDER KEITH 117d overdue
17614045 LOW-VOLUME SYSTEMS FOR SAMPLE IDENTIFICATION GZYBOWSKI, MICHAEL STANLEY 112d overdue

Interview Candidates (33)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17583726 SYSTEM AND METHODS FOR IMPLEMENTING PRIVATE IDENTITY CHAMPAKESAN, BADRI NARAYANAN 71d overdue
18754457 SYSTEM AND METHODS FOR IMPLEMENTING PRIVATE IDENTITY CHAMPAKESAN, BADRI NARAYANAN 38d overdue
18754422 SYSTEM AND METHODS FOR IMPLEMENTING PRIVATE IDENTITY CHAMPAKESAN, BADRI NARAYANAN 38d overdue
16781732 COMBINATION GENE TARGETS FOR IMPROVED IMMUNOTHERAPY SHIN, DANA H 28d overdue
16324945 A20 THERAPY TO ACHIEVE GLYCEMIC CONTROL SHIN, DANA H 15d
18267144 METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D KONOPKA, CATHERINE ANNE 20d
18278394 INTERCELLULAR ADHESION MOLECULE 1 (ICAM1) ANTIBODY DRUG CONJUGATE AND USES THEREOF BENAVIDES, JENNIFER ANN 27d
19202001 ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF POHNERT, STEVEN C 33d

Client Portfolio (294 clients)

View all 294 →

Top Art Units

Art UnitApps
163315
168313
163511
163711
163110
16189
16289
37859
16329
16829

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19542772 ANTI-INTERLEUKIN-11 ANTIBODIES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH DEBERRY, REGINA M 1647 §112 Non-Final OA — Pending Feb 18, 2026
19535590 FATTY ACID COMPOSITIONS Fera Diagnostics And Biologicals Corp. CHONG, YONG SOO 1623 §102 Final Rejection — Pending Feb 10, 2026
19423243 PHASE-CHANGE MATERIAL SWITCH Centre National De La Recherche Scientifique ENDRESEN, KIRSTEN DANIELA 2874 §103§112 Non-Final OA — Pending Dec 17, 2025
19388923 LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF Beijing Inno Medicine Co., Ltd. DICKINSON, PAUL W 1618 §103§112Other Non-Final OA — Pending Nov 13, 2025
19366359 BYZANTINE FAULT TOLERANCE FOR INSTANT PAYMENT AND METHODS OF PERFORMING THE SAME 1Money Co. SHAHABI, ARI ARASTOO 3697 §101 Final Rejection — Pending Oct 22, 2025
19351076 SYSTEMS AND METHODS FOR AUTOMATED PROCESS DISCOVERY Soroco India Private Limited SHECHTMAN, CHERYL MARIA 2164 §101§103 Non-Final OA — Pending Oct 06, 2025
19347384 SYSTEMS AND METHODS FOR TRANSFORMER INTEGRATION INTO DYNAMIC SCHEMA DATABASES Mongodb, Inc. YEN, SYLING 2166 §101§103 Non-Final OA — Pending Oct 01, 2025
19328038 INTEGRATED DILUTION REFRIGERATORS Maybell Quantum Industries, Inc. NOUKETCHA, LIONEL W 3763 §103 Non-Final OA — Pending Sep 12, 2025
19325798 ELECTRICAL ENERGY SYSTEM, VEHICLE AND METHOD Samsung Electronics WARMFLASH, MICHAEL J 2836 §102§103 Non-Final OA — Pending Sep 11, 2025
19324017 CANDIDATE ANALYSIS TECHNIQUES FOR RECRUITING SYSTEMS Scout Exchange LLC LAKHANI, ANDREW C 3629 §101§102§103 Non-Final OA — Pending Sep 09, 2025
19283108 DEPORTED COMPUTE FOR TELEOPERATION AND AUTONOMOUS SYSTEMS Teleo LLC LI, CE LI 3661 DP Final Rejection — Pending Jul 28, 2025
19224303 MACHINE LEARNING MODEL TRAINED USING ARTIFICIAL CELL-FREE RNA (CFRNA) EXPRESSION DATA Bostongene Corporation PAULS, JOHN A 3683 §101§103 Non-Final OA — Pending May 30, 2025
19220663 TAMPER RESISTANT LOCK SYSTEM Securitech Group, Inc. MERLINO, ALYSON MARIE 3675 §112 Non-Final OA — Pending May 28, 2025
19219076 POWER CONVERTER, POWER SYSTEM, AND METHOD FOR CONTROLLING POWER CONVERTER Sungrow (Shanghai) Co., Ltd. MOURAD, RASEM 2836 §102§103 Non-Final OA — Pending May 27, 2025
19218957 Rückführungssystem zum Rückführen von rezirkuliertem Antriebs-Flüssiggas, betreffendes Verfahren sowie Verwendung Tge Marine Gas Engineering GmbH GREENE, MARK L 3747 §101§102§103§112 Non-Final OA — Pending May 27, 2025
19202001 ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF Valneva Usa, Inc. POHNERT, STEVEN C 1683 §112Other Non-Final OA 33d Pending May 08, 2025
19200934 DEADBOLT LOCK Assa Abloy Access And Egress Hardware Group, Inc. WATSON, PETER HUCKLEBERRY 3675 §102§103 Final Rejection — Pending May 07, 2025
19196950 HYDROGEN FUELING SYSTEMS AND METHODS Ivys Inc. SHRIEVES, STEPHANIE ALEXANDRA 3753 §103 Non-Final OA — Pending May 02, 2025
19197851 FIREARM MAGAZINE ENGAGEMENT MECHANISMS AND RELATED TECHNIQUES Henry Rac Holding Corp. D/B/A Henry Repeating Arms CLEMENT, MICHELLE RENEE 3641 §102§112 Non-Final OA 39d Pending May 02, 2025
19123207 HELMET Shoei Co., Ltd. NGUYEN, BAO-THIEU L 3732 §103§112 Non-Final OA — Pending Apr 22, 2025
19184594 SELF-PROTECTING DOOR HANDLE ASSEMBLY Sargent Manufacturing Company AHMAD, FARIA F 3675 §102§103 Final Rejection — Pending Apr 21, 2025
19122695 BAG SUPPORT AND ASSOCIATED METHOD, TRANSPORT SYSTEM AND SUPPORT STRUT Almar Packaging (Pty) Ltd. WILKENS, JANET MARIE 3637 §102§103 Non-Final OA — Pending Apr 18, 2025
19120119 SELF-CHECKING-BASED FIRE-FIGHTING AIR INTAKE AND DISCHARGE CONTROL SYSTEM, AND CONTROL METHOD Sungrow Power Supply Co., Ltd. LEE, CHEE-CHONG 3752 §102§103§112 Non-Final OA — Pending Apr 10, 2025
19174403 SYSTEMS AND METHODS FOR OPTIMIZING THE CONVERSION OF FEEDSTOCK INTO RENEWABLE ENERGY Vanguard Renewables Holdings, LLC LUDWIG, PETER L 3627 §101§103§112 Final Rejection 5d overdue Pending Apr 09, 2025
19093525 ADDITIVE MANUFACTURING ON PLIABLE SUBSTRATES Opt Industries, Inc. AHMED ALI, MOHAMED K 1743 §103§112 Non-Final OA — Pending Mar 28, 2025
19094303 METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER Xenon Pharmaceuticals Inc. SOROUSH, LAYLA 1622 §103DP Final Rejection 14d Pending Mar 28, 2025
19091004 TECHNIQUES FOR VIRTUAL VISUALIZATION OF A PRODUCT IN A PHYSICAL SCENE Wayfair LLC HE, YINGCHUN 2613 §103Other Non-Final OA — Pending Mar 26, 2025
19114617 OPTOELECTRONIC DEVICE Aledia YODICHKAS, ANEETA 2627 §103§112 Final Rejection 28d Pending Mar 24, 2025
19088753 HEALTHY POWDERED OR GRANULATED SWEETENER Sugar License LLC JACOBSON, MICHELE LYNN 1793 §103§112DP Non-Final OA — Pending Mar 24, 2025
19114147 OPTOELECTRONIC DEVICE Aledia ENGLISH, ALECIA DIANE 2625 §103 Non-Final OA 8d Pending Mar 21, 2025
19087234 MANUFACTURING LIGHT FIELD PRINTS Fathom Optics Inc. BANH, DAVID H 2853 §102§103 Final Rejection 1d overdue Pending Mar 21, 2025
19087126 PRESS MOLD APPARATUS FOR MANUFACTURING Samsung Electronics BERNARD, ADRIEN J 1741 §103 Non-Final OA — Pending Mar 21, 2025
19082945 DESIGNS FOR ENHANCED RELIABILITY AND CALIBRATION OF LANDFILL GAS MEASUREMENT AND CONTROL DEVICES Loci Controls, Inc. MERCADO, ALEXANDER A 2855 §103Other Non-Final OA — Pending Mar 18, 2025
19076014 TECHNIQUES FOR CAPTURING SOFTWARE APPLICATION SESSION REPLAY DATA FROM DEVICES Logrocket, Inc. EHNE, CHARLES 2113 §102 Non-Final OA — Pending Mar 11, 2025
19072186 SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF Pogona, LLC JACKSON-TONGUE, LAKIA J 1645 §102Other Non-Final OA — Pending Mar 06, 2025
19107541 CONNECTION STRUCTURE AND BUILDING ROOF Sekisui House, Ltd. PATTERSON, GARRETT CHRISTOPHER 3633 §103§112 Non-Final OA — Pending Feb 27, 2025
19107523 PHOTOVOLTAIC SYSTEM AND CONTROL METHOD Sungrow Power Supply Co., Ltd. PATEL, DHARTI HARIDAS 2838 §102§103§112 Non-Final OA — Pending Feb 27, 2025
19063699 OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS Wista Laboratories Ltd. PALLAY, MICHAEL B 1617 §103Other Non-Final OA — Pending Feb 26, 2025
19062432 ENERGY STORAGE CABINET Sungrow Power Supply Co., Ltd. HANSEN, JAMES ORVILLE 3637 §102§103 Non-Final OA — Pending Feb 25, 2025
19105596 INJECTION ATTACK PREVENTION FOR DIGITAL IDENTITY VERIFICATION Pxl Vision AG SONG, HOSUK 2435 §102 Non-Final OA — Pending Feb 21, 2025
19105648 METHOD AND APPARATUS FOR IMPROVED ULTRASONIC FORMATION Soni-Form LLC SCHIFFMAN, BENJAMIN A 1742 §103 Non-Final OA — Pending Feb 21, 2025
19057629 SYSTEMS AND METHODS FOR PERFORMING MEDICAL TASKS USING A MEDICAL ARTIFICIAL INTELLIGENCE SYSTEM President and Fellows of Harvard College ILAGAN, VINCENT CAESAR 3686 §101§102§103 Non-Final OA 79d Pending Feb 19, 2025
19103663 CONNECTION STRUCTURE AND ROOF OF BUILDING Sekisui House, Ltd. PATTERSON, GARRETT CHRISTOPHER 3633 §102§103 Non-Final OA — Pending Feb 13, 2025
19052178 Mobile Payment Station System and Method Mobile Equity Corp. ADE, OGER GARCIA 3627 DP Non-Final OA — Pending Feb 12, 2025
19050440 WIRELESS AUDIO TRANSMISSION SYSTEM Sennheiser Electronic SE & Co. Kg TESHALE, AKELAW 2694 §103 Non-Final OA — Pending Feb 11, 2025
19045994 NANOSENSOR METHODS AND APPARATUSES FOR DETERMINATION OF ANALYTES President and Fellows of Harvard College GIERE, REBECCA M 1677 §103DP Non-Final OA — Pending Feb 05, 2025
19045273 QUICK ATTACHMENT SYSTEM Mavrik, Inc. GORDON, ANNA L 3642 §102§103§112 Final Rejection — Pending Feb 04, 2025
19044290 SYSTEMS AND METHODS FOR PRIVATE AUTHENTICATION WITH HELPER NETWORKS Private Identity LLC CHAMPAKESAN, BADRI NARAYANAN 2494 §103Other Non-Final OA — Pending Feb 03, 2025
19042823 BIOMETRIC AUTHENTICATION Private Identity LLC ALMAGHAYREH, KHALID M 2492 §103§112 Non-Final OA — Pending Jan 31, 2025
19041179 MOBILE DEVICE WITH HEADPHONE AMPLIFIER Sennheiser Electronic SE & Co. Kg SHAH, ANTIM G 2693 §102§103§112 Non-Final OA — Pending Jan 30, 2025

View all 651 →

Managing Wolf, Greenfield & Sacks, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Wolf, Greenfield & Sacks, P.C.'s patent allowance rate?

84.9% of resolved applications prosecuted by Wolf, Greenfield & Sacks, P.C. were allowed, across 35,769 applications in USPTO records.

How many office actions does Wolf, Greenfield & Sacks, P.C. average before allowance?

3.61 office actions per allowed application on average.

How many pending office actions does Wolf, Greenfield & Sacks, P.C. have?

651 pending office actions as of October 2026, for 294 clients, before 549 examiners in 248 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month